The recipient reportedly experienced an infection and skin flap breakdown.In (b)(6) 2019, the recipient presented with pain and discharge at the implant site.The recipient was prescribed a two weeks course of oral antibiotic.On (b)(6) 2019, the recipient was prescribed a course of clindamycin.On (b)(6) 2019, the recipient presented with device extrusion and the recipient was hospitalized for iv antibiotics.On (b)(6) 2020 the recipient's device was explanted.The recipient's infection resolved and wound healed.On (b)(6) 2020, the recipient was reimplanted with another advanced bionics cochlear device.The recipient¿s device will not return to advanced bionics for analysis.
|